MassBank MassBank Search Contents Download

MassBank Record: KO003409

3-Methylguanine; LC-ESI-QQ; MS2; CE:30 V; [M+H]+

Mass Spectrum
Chemical Structure
Generated by the Chemistry Development Kit (http://github.com/cdk)

ACCESSION: KO003409
RECORD_TITLE: 3-Methylguanine; LC-ESI-QQ; MS2; CE:30 V; [M+H]+
DATE: 2016.01.19 (Created 2007.07.07, modified 2011.05.10)
AUTHORS: Kakazu Y, Horai H, Institute for Advanced Biosciences, Keio Univ.
LICENSE: CC BY-NC-SA
COMMENT: KEIO_ID M042

CH$NAME: 3-Methylguanine
CH$NAME: 2-Amino-3,7-dihydro-3-methyl-6H-purin-6-one
CH$COMPOUND_CLASS: N/A
CH$FORMULA: C6H7N5O
CH$EXACT_MASS: 165.06506
CH$SMILES: CN1C2=C(C(=O)N=C1N)NC=N2
CH$IUPAC: InChI=1S/C6H7N5O/c1-11-4-3(8-2-9-4)5(12)10-6(11)7/h2H,1H3,(H,8,9)(H2,7,10,12)
CH$LINK: CAS 2958-98-7
CH$LINK: KEGG C02230
CH$LINK: NIKKAJI J101.565F
CH$LINK: PUBCHEM SID:5294
CH$LINK: INCHIKEY XHBSBNYEHDQRCP-UHFFFAOYSA-N
CH$LINK: COMPTOX DTXSID90183755

AC$INSTRUMENT: API3000, Applied Biosystems
AC$INSTRUMENT_TYPE: LC-ESI-QQ
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V

MS$FOCUSED_ION: PRECURSOR_M/Z 166
MS$FOCUSED_ION: PRECURSOR_TYPE [M+H]+

PK$SPLASH: splash10-00dj-9300000000-a69603f1c727d6e9b676
PK$NUM_PEAK: 30
PK$PEAK: m/z int. rel.int.
  41.300 297030.0 50
  43.200 74257.5 12
  45.100 930694.0 156
  56.900 39604.0 7
  59.100 579208.5 97
  68.900 138614.0 23
  70.100 29703.0 5
  71.100 524753.0 88
  73.200 5945550.5 999
  75.100 158416.0 27
  80.300 24752.5 4
  83.100 44554.5 7
  85.000 272277.5 46
  87.100 79208.0 13
  89.000 108911.0 18
  94.300 79208.0 13
  96.100 173267.5 29
  96.800 44554.5 7
  97.400 44554.5 7
  99.300 39604.0 7
  104.900 34653.5 6
  119.800 24752.5 4
  120.900 133663.5 22
  123.300 128713.0 22
  124.200 430693.5 72
  130.200 108911.0 18
  133.700 24752.5 4
  149.200 2341586.5 393
  150.900 34653.5 6
  166.300 836634.5 141
//

Imprint Feedback
system version 2.1.8
Copyright © 2006 MassBank Project; 2011 NORMAN Association; 2021 MassBank Consortium
Responsible: Dr. Tobias Schulze